These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 38116528)

  • 41. Micronutrient Requirements and Sharing Capabilities of the Human Gut Microbiome.
    Rodionov DA; Arzamasov AA; Khoroshkin MS; Iablokov SN; Leyn SA; Peterson SN; Novichkov PS; Osterman AL
    Front Microbiol; 2019; 10():1316. PubMed ID: 31275260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine.
    Mousa S; Sarfraz M; Mousa WK
    Metabolites; 2023 May; 13(5):. PubMed ID: 37233715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time-Series-Dependent Global Data Filtering Strategy for Mining and Profiling of Xenobiotic Metabolites in a Dynamic Complex Matrix: Application to Biotransformation of Flavonoids in the Extract of
    Wang HY; Qu C; Li MN; Li CR; Liu RZ; Guo Z; Li P; Gao W; Yang H
    J Agric Food Chem; 2022 Nov; 70(45):14386-14394. PubMed ID: 36331925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Host-microbiome metabolism of a plant toxin in bees.
    Motta EVS; Gage A; Smith TE; Blake KJ; Kwong WK; Riddington IM; Moran N
    Elife; 2022 Dec; 11():. PubMed ID: 36472498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.
    Kirchmair J; Williamson MJ; Tyzack JD; Tan L; Bond PJ; Bender A; Glen RC
    J Chem Inf Model; 2012 Mar; 52(3):617-48. PubMed ID: 22339582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The gut microbiome influences the bioavailability of olanzapine in rats.
    Cussotto S; Walsh J; Golubeva AV; Zhdanov AV; Strain CR; Fouhy F; Stanton C; Dinan TG; Hyland NP; Clarke G; Cryan JF; Griffin BT
    EBioMedicine; 2021 Apr; 66():103307. PubMed ID: 33819741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tutorial: Microbiome studies in drug metabolism.
    Dodd D; Cann I
    Clin Transl Sci; 2022 Dec; 15(12):2812-2837. PubMed ID: 36099474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Connecting the dots: Targeting the microbiome in drug toxicity.
    Luo Y; Zhou T
    Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut colonisation by extended-spectrum β-lactamase-producing Escherichia coli and its association with the gut microbiome and metabolome in Dutch adults: a matched case-control study.
    Ducarmon QR; Zwittink RD; Willems RPJ; Verhoeven A; Nooij S; van der Klis FRM; Franz E; Kool J; Giera M; Vandenbroucke-Grauls CMJE; Fuentes S; Kuijper EJ
    Lancet Microbe; 2022 Jun; 3(6):e443-e451. PubMed ID: 35659906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of gut microbiota in the pharmacokinetics of antihypertensive drugs.
    Choi MS; Yu JS; Yoo HH; Kim DH
    Pharmacol Res; 2018 Apr; 130():164-171. PubMed ID: 29391236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
    J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolism of drugs and other xenobiotics in the gut lumen and wall.
    Ilett KF; Tee LB; Reeves PT; Minchin RF
    Pharmacol Ther; 1990; 46(1):67-93. PubMed ID: 2181492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota.
    Lindell AE; Zimmermann-Kogadeeva M; Patil KR
    Nat Rev Microbiol; 2022 Jul; 20(7):431-443. PubMed ID: 35102308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins.
    Koppel N; Bisanz JE; Pandelia ME; Turnbaugh PJ; Balskus EP
    Elife; 2018 May; 7():. PubMed ID: 29761785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization and Spatial Mapping of the Human Gut Metasecretome.
    Velez-Cortes F; Wang H
    mSystems; 2022 Dec; 7(6):e0071722. PubMed ID: 36468852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut microbiome interactions with drug metabolism, efficacy, and toxicity.
    Wilson ID; Nicholson JK
    Transl Res; 2017 Jan; 179():204-222. PubMed ID: 27591027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease.
    Heinken A; Ravcheev DA; Baldini F; Heirendt L; Fleming RMT; Thiele I
    Microbiome; 2019 May; 7(1):75. PubMed ID: 31092280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms.
    Boccuto L; Tack J; Ianiro G; Abenavoli L; Scarpellini E
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flavonoid-Modifying Capabilities of the Human Gut Microbiome-An In Silico Study.
    Goris T; Cuadrat RRC; Braune A
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mapping human microbiome drug metabolism by gut bacteria and their genes.
    Zimmermann M; Zimmermann-Kogadeeva M; Wegmann R; Goodman AL
    Nature; 2019 Jun; 570(7762):462-467. PubMed ID: 31158845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.